The House Goes Long On Drones
Client Alert | 1 min read | 09.20.22
Last week, the House passed the Drone Infrastructure Inspection Grant Act, which establishes programs within the Department of Transportation (DOT) to support the use of small unmanned aircraft systems (sUAS) when inspecting, repairing, or constructing a variety of types of infrastructure, including roads, electric grids, water, and other critical infrastructure.
Specifically, the legislation authorizes DOT to award up to $100 million over two years in grants to state, tribal and local governments to support their purchase and use of sUAS to increase efficiency, reduce costs, improve worker safety, and reduce carbon emissions when carrying out infrastructure inspections, repairs, and construction. In addition to the customary flowdown requirements that accompany grant funding, the infrastructure inspection grants will include mandatory country of origin provisions, requiring grant recipients to use U.S.-manufactured sUAS made by companies not subject to Chinese influence or control.
The legislation also authorizes a separate $100 million pool of funding for DOT to use for grants to educational institutions to support student training and education in the use of drones and related technologies.
The bill, which passed the House by a 308-110 vote, now proceeds to the Senate. A companion bill was introduced in the Senate on August 8 and has been referred to the Committee on Commerce, Science, and Transportation for consideration. Both bills have significant support from industry leaders and local government groups.
Contacts
Insights
Client Alert | 3 min read | 11.17.26
CMS Final OPPS Rule Will Reduce Reimbursement for 340B Drugs
On November 6, 2026, the Centers for Medicare and Medicaid Services (CMS) published its final 2027 Medicare Hospital Outpatient Perspective Payment System (OPPS) rule. The rule will reduce reimbursement for 340B drugs from average sales price (ASP) plus 6% (what Medicare generally pays for Part B outpatient drugs administered by providers) to ASP minus 28%, a 32% reduction. CMS originally proposed reducing reimbursement to ASP minus 33.4%. CMS indicated that this change will better align Medicare reimbursement with hospitals’ costs of acquiring 340B drugs.
Client Alert | 9 min read | 11.17.26
Priorities and Prospects for AI Legislation in the New Congress
Client Alert | 8 min read | 11.16.26
OCC’s AI Examiner Framework: How Banks’ AI Use Can Trigger Legal Liability and Supervisory Exposure
Client Alert | 3 min read | 11.13.26
Massachusetts Trade Secret Preliminary Injunctions: Prove the Harm, Tailor the Relief



